Presentation TCT 2016 Device Specifications and Clinical Program Update: Desyne BD Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa October 31, 2016
Presentation TCT 2016 TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From Four Centers Presenter: Nicolas Foin, Giampaolo Niccoli October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Orbus-Neich Combo Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Biomime Presenter: Alexandre Abizaid, Ashok Seth October 31, 2016
Presentation TCT 2016 Device Specifications and Clinical Program Update: Alex Presenter: Alexandre Abizaid, Ashok Seth, Dariusz Dudek October 31, 2016
Presentation TCT 2016 Device and Clinical Program Highlights: Abluminus Presenter: Alexandre Abizaid, Ashok Seth, Dinesh Shah October 31, 2016
Presentation TCT 2016 Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Second Generation Durable Polymer DES are the Gold Standard and Remain Superior to Bioabsorbable Polymer DES! Presenter: Stephan Windecker, Tullio Palmerini October 31, 2016
Presentation TCT 2016 Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES! Presenter: Stephan Windecker, Michael Joner October 31, 2016
Presentation TCT 2016 Featured Lecture: Overview of Currently Available and Under Development Bioabsorbable Polymer-based DES Programs. Are There Meaningful Differences? Presenter: Stephan Windecker, Julinda Mehilli October 31, 2016
Presentation TCT 2016 NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen October 31, 2016
Presentation TCT 2016 Potential Advantages and Pitfalls of Bioabsorbable Polymers Presenter: Stephan Windecker, Renu Virmani October 31, 2016
Presentation TCT 2016 EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone October 31, 2016
Presentation TCT 2016 The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari October 31, 2016
Presentation TCT 2016 Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber October 31, 2016
Presentation TCT 2016 Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik October 31, 2016
Presentation TCT 2016 Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner October 31, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016